This pivotal program examines and reviews the latest information regarding hepatitis C elimination, including where global and national progress has succeeded and stalled; what treatment strategies could get us back on track; and what prevention strategies are still needed.
Presenters in this session discuss advances in our understanding of hepatic hypoxia and its contribution to liver physiology and pathology. The concepts covered by thought leaders and content experts include an overview of hypoxia, regulation of liver zonation by hypoxia, and the central role of hypoxia in regulating the gut-liver axis. Presenters also address the role of hypoxia in hepatic conditions such as acute liver injury, liver fibrosis, steatosis, and hepatocellular carcinoma.
Join this critical discussion of the most notable and influential clinical research papers published in the journal HEPATOLOGY in the past year by a team of associate editors from the journal. HEPATOLOGY associate editors Yujin Hoshida, Jennifer Lai, and Manal Abdelmalek appraise the most cutting-edge, game changing clinical science research advances. A panel discussion with the speakers, editor-in-chief Gregory Gores, and associate editor Jacqueline O'Leary highlights the clinical impact of selected papers, and key challenges and opportunities in the field.
Join an expert panel who provide a comprehensive overview of congenital portosystemic shunts in children, emphasizing the underlying vascular anatomy, embryologic development, and spectrum of anatomic variants. Presenters review the natural history of these lesions and their associated clinical sequelae, including hepatic dysfunction, pulmonary vascular complications, neurocognitive effects, and implications for growth and development.
Through discussion of real-life clinical cases, speakers illustrate diagnostic evaluation, risk stratification, and timing of intervention, highlighting how patient-specific factors influence management decisions. A multidisciplinary approach is emphasized with input from hepatology, interventional radiology, surgery, cardiology, and transplant teams. Potential interventions are explored in detail, including indications, technical considerations, and outcomes of endovascular and surgical strategies, as well as scenarios in which liver transplantation may be required. Long-term surveillance and follow-up after intervention are also addressed.
Kathy Pariani is a Registered Dietitian Nutritionist and Certified Diabetes Education Care and Specialist. Kathy provides nutrition assessments, education and counseling to patients with chronic diseases, specifically those with liver disease, diabetes, obesity and cardiovascular risk factors. Kathy previously practiced as an acupuncturist and herbalist before earning her Master's degree in Nutrition and Dietetics from Bastyr University.
Summer Collier, DNP, FNP-BC, is a board-certified Family Nurse Practitioner specializing in hepatology at UC San Diego Health. She has led initiatives to improve care delivery for patients with advanced liver disease, including the development of a transitions-of-care program for patients with cirrhosis that significantly reduced early hospital readmissions. Her scholarly work has also focused on increasing the use of pharmacotherapy for alcohol use disorder in the hepatology setting.
Becky Klemme is a Nurse Practitioner with Avera Medical Group Liver Disease in Sioux Falls, South Dakota. She completed both her undergraduate and graduate degrees at South Dakota State University. In 2014 she completed the AASLD NP PA Fellowship program. She has been practicing in Hepatology since that time. She was the 2020 South Dakota NP of the year and the 2021 South Dakota State University Nurse of the year. She is a faculty ambassador for Gastroenterology & Hepatology Advanced Practice Providers (GHAPP).
Jeremy Davis is a hepatology advanced practice provider at GastroIntestinal Specialists in Shreveport, Louisiana. He has provided hepatology/ gastroenterology care in the outpatient and inpatient setting for over the past 14 years. He is an associate member of AASLD. He is passionate about learning. He is an active contributor as a lecturer providing continuing education as it relates to hepatology to other healthcare providers through local, regional and national opportunities.
Allison Moser has been a nurse practitioner for 12 years, with the past 8 years dedicated to specializing in hepatology. She currently serves as the Lead Advanced Practice Provider of Solid Organ Transplant at Rush University Medical Center in Chicago, IL. She has been a member of the Illinois Board of Directors for the American Liver Foundation (ALF) and has co-chaired the Associate Medical Advisory Committee (AMAC).
Esther Fasanmi is a clinical pharmacist responsible for providing pharmacotherapy care for those living with HIV and hepatology related conditions. She is a preceptor for family medicine medical residents, pharmacy residents, and students and serves as a clinical expert for other healthcare providers. Dr. Fasanmi received her Doctorate of Pharmacy from Texas Southern University College of Pharmacy and Health Sciences.